.jpeg)
What disease does bosutinib treat?
Bosutinib is a tyrosine kinase inhibitor mainly used to treat chronic myeloid leukemia (CML, Chronic Myeloid Leukemia). CML is a bone marrow disease caused by abnormal white blood cell proliferation, often accompanied by chromosomal abnormalities. Bosutinib helps control the disease by inhibiting the activity of specific tyrosine kinases, blocking the growth and proliferation of abnormal white blood cells. The drug is usually used as part of targeted therapy, targeting specific molecular targets to reduce the impact on normal cells and improve the therapeutic effect. Before starting bosutinib, patients receive a detailed evaluation and their doctors develop a treatment plan on an individual basis and monitor their response regularly.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
